Recent Advances in Preventing Adverse Reactions to Transfusion [version 1; referees: 4 approved]

The spectrum of adverse reactions to blood product transfusion ranges from a benign clinical course to serious morbidity and mortality. There have been many advances in technologies and transfusion strategies to decrease the risk of adverse reactions. Our aim is to address a few of the advancements in increasing the safety of the blood supply, specifically pathogen reduction technologies, bacterial contamination risk reduction, and transfusion associated acute lung injury risk mitigation strategies. Thomas S Rogers ( ) Corresponding author: [email protected] Rogers TS, Fung MK and Harm SK. How to cite this article: Recent Advances in Preventing Adverse Reactions to Transfusion [version 1; 2015, (F1000 Faculty Rev):1469 (doi: ) referees: 4 approved] F1000Research 4 10.12688/f1000research.7048.1 © 2015 Rogers TS . This is an open access article distributed under the terms of the , which Copyright: et al Creative Commons Attribution Licence permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) declared that no grants were involved in supporting this work. Grant information: Competing interests: The authors declare that they have no competing interests. 17 Dec 2015, (F1000 Faculty Rev):1469 (doi: ) First published: 4 10.12688/f1000research.7048.1 1,2 1,2